CEO exercised or converted 4,991 RMD derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 7, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 9, 2026
CEOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000943819-26-000003
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly Reporting personMichael J. Farrell RelationshipDirector, Officer Officer titleChairman and CEO SecurityResMed Common Stock TableNon-derivative (Table I) Transaction dateJan 7, 2026 Acquired / disposedAcquired (A) Shares owned after471,214 Footnotes from the filing
- The transaction was conducted under a Rule 10b5-1 plan adopted October 31, 2024.